Hetero-substituted cyclic lactone analogues and uses thereof
US11021488B2 · kind B2 · utility
0Cited by
12References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 26, 2019 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Jul 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides SL and SL derivatives comprising a polar substituent adjacent to the lactone ring. Additionally, the present disclosure provides methods of using the SL and SL derivatives to inhibit the growth of leukemic cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.